In vitro and animal-model studies have examined its interaction with angiogenic, nitric-oxide, and growth-factor signalling pathways relevant to soft-tissue research
While combining keto and GLP1-s safely can be done, there is no evidence that a keto diet combined with GLP-1s is more effective long-term
With the rising popularity of GLP-1 drugs for weight loss, you likely face a pressing question: How long can these medications realistically be used as part of a sustainable health strategy
The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
Incretin-like hormones, such as glucagon-like peptide-1 (GLP-1), exert their effects by inducing glucose-dependent effects on insulin secretion, inhibiting glucagon release, slowing gastric emptying, and reducing food intake, ultimately leading to weight loss [5, 6]
Notably, sex-related differences in weight reduction became more pronounced with increasing degrees of weight loss and in trials with longer treatment durations [55]